Values First Advisors’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $615K | Sell |
|
|||||
|
2025
Q2 | $546K | Buy |
|
|||||
|
2025
Q1 | $497K | Sell |
|
|||||
|
2024
Q4 | $484K | Sell |
|
|||||
|
2024
Q3 | $711K | Buy |
|
|||||
|
2024
Q2 | $547K | Buy |
|
|||||
|
2024
Q1 | $619K | Sell |
|
|||||
|
2023
Q4 | $1.04M | Sell |
|
|||||
|
2023
Q3 | $972K | Buy |
|
|||||
|
2023
Q2 | $794K | Buy |
|
|||||
|
2023
Q1 | $711K | Sell |
|
|||||
|
2022
Q4 | $1.1M | Buy |
|
|||||
|
2022
Q3 | $728K | Sell |
|
|||||
|
2022
Q2 | $852K | Buy |
|
|||||
|
2022
Q1 | $929K | Buy |
|
|||||
|
2021
Q4 | $790K | Buy |
|
|||||
|
2021
Q3 | $825K | Buy |
|
|||||
|
2021
Q2 | $880K | Buy |
|
|||||
|
2021
Q1 | $780K | Sell |
|
|||||
|
2020
Q4 | $782K | Buy |
|
|||||
|
2020
Q3 | $650K | Buy |
|
|||||
|
2020
Q2 | $425K | Sell |
|
|||||
|
2020
Q1 | $398K | Sell |
|
|||||
|
2019
Q4 | $815K | Buy |
|